tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ELTX Stock Latest News

Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
The FlyElicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
3d ago
ELTX
Elicio Therapeutics announces investigator-initiated Phase 1 trial of ELI-002 7P
PremiumThe Fly
Elicio Therapeutics announces investigator-initiated Phase 1 trial of ELI-002 7P
1M ago
ELTX
Elicio Therapeutics reports inducement grants
PremiumThe Fly
Elicio Therapeutics reports inducement grants
1M ago
ELTX
Elicio Therapeutics Announces Promising Phase 2 Vaccine Results
PremiumCompany Announcements
Elicio Therapeutics Announces Promising Phase 2 Vaccine Results
1M ago
8K
ELTX
Elicio reports ELI-002 7P induced T cell responses in 99% of patients
PremiumThe Fly
Elicio reports ELI-002 7P induced T cell responses in 99% of patients
1M ago
ELTX
Elicio Therapeutics Publishes Promising Phase 1 Study Data
PremiumCompany AnnouncementsElicio Therapeutics Publishes Promising Phase 1 Study Data
3M ago
8K
ELTX
Elicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 data
Premium
The Fly
Elicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 data
3M ago
ELTX
Elicio Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Elicio Therapeutics Reports Q2 2025 Financial Results
3M ago
ELTX
Elicio Therapeutics Advances Phase 2 AMPLIFY-7P Study
PremiumCompany Announcements
Elicio Therapeutics Advances Phase 2 AMPLIFY-7P Study
3M ago
8K
ELTX
Elicio announces positive recommendation by IDMC to continue ELI-002 Phase 2
PremiumThe Fly
Elicio announces positive recommendation by IDMC to continue ELI-002 Phase 2
3M ago
ELTX
Elicio Therapeutics: Promising Trial Results and Commercial Potential Drive Buy Rating
PremiumRatings
Elicio Therapeutics: Promising Trial Results and Commercial Potential Drive Buy Rating
4M ago
ELTX
Elicio Therapeutics price target raised to $13 from $10 at H.C. Wainwright
PremiumThe Fly
Elicio Therapeutics price target raised to $13 from $10 at H.C. Wainwright
4M ago
ELTX
Elicio Therapeutics to host virtual KOL event on AMP-powered ELI-002
PremiumThe FlyElicio Therapeutics to host virtual KOL event on AMP-powered ELI-002
5M ago
ELTX
Elicio Therapeutics Secures $10M Financing for Operations
Premium
Company Announcements
Elicio Therapeutics Secures $10M Financing for Operations
5M ago
8K
ELTX
Elicio Therapeutics secures $10M in financing
Premium
The Fly
Elicio Therapeutics secures $10M in financing
5M ago
ELTX
Elicio Therapeutics Elects New Directors at Annual Meeting
PremiumCompany Announcements
Elicio Therapeutics Elects New Directors at Annual Meeting
5M ago
8K
ELTX
Elicio Therapeutics reports Q1 EPS (87c), consensus (83c)
PremiumThe Fly
Elicio Therapeutics reports Q1 EPS (87c), consensus (83c)
6M ago
ELTX
Seven new option listings and one option delisting on April 16th
PremiumThe Fly
Seven new option listings and one option delisting on April 16th
7M ago
AVTX
CARA
Elicio Therapeutics: Buy Rating Backed by Financial Stability and Promising ELI-002 7P Developments
PremiumRatings
Elicio Therapeutics: Buy Rating Backed by Financial Stability and Promising ELI-002 7P Developments
7M ago
ELTX
Elicio Therapeutics Advances Cancer Immunotherapy Pipeline
PremiumCompany AnnouncementsElicio Therapeutics Advances Cancer Immunotherapy Pipeline
7M ago
ELTX
Elicio Therapeutics reports FY24 EPS ($4.25) vs ($6.96) last year
Premium
The Fly
Elicio Therapeutics reports FY24 EPS ($4.25) vs ($6.96) last year
7M ago
ELTX
ELTX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ELTX Earnings this Week: How Will it Perform?
7M ago
ELTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >